DrugPatentWatch Database Preview
Drugs in Development Information for Mephedrone
» See Plans and Pricing
What is the development status for investigational drug Mephedrone?
Mephedrone is an investigational drug.
There have been 3 clinical trials for Mephedrone.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 30th 2020.
The most common disease conditions in clinical trials are Amphetamine-Related Disorders, Disease, and Alcohol-Related Disorders. The leading clinical trial sponsors are Instituto de Salud Carlos III, Parc de Salut Mar, and Fundacio Lluita Contra la SIDA.
Summary for Mephedrone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 268 |
| WIPO Patent Applications | 294 |
| Japanese Patent Applications | 193 |
| Clinical Trial Progress | Phase 1 (2020-01-30) |
| Vendors | 0 |
Recent Clinical Trials for Mephedrone
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat | Fundacio Lluita Contra la SIDA | Phase 1 |
| Mephedrone and Alcohol Interactions in Humans | Instituto de Salud Carlos III | Phase 1 |
| Mephedrone and Alcohol Interactions in Humans | Parc de Salut Mar | Phase 1 |
Clinical Trial Summary for Mephedrone
Top disease conditions for Mephedrone
Top clinical trial sponsors for Mephedrone
US Patents for Mephedrone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
